Momenta Pharmaceuticals

FDA approves Glatopa a generic option for relapsing forms of multiple sclerosis

14 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

Sandoz has announced that the FDA has approved and launch of Glatopa as a fully-substitutable, AP-rated generic version of Copaxone for relapsing forms of MS...